Acs Management Following Dual Antiplatelet Therapy

ACS Management Following Dual Antiplatelet Therapy

Advances in Dual Antiplatelet Therapy for Acute Coronary Syndrome (ACS)

torontoheartcentre

Challenges in Dual Antiplatelet Therapy (DAPT) Following Percutaneous Cardiac Intervention (PCI)

McMaster University - Department of Medicine

MASTER DAPT trial: Dual antiplatelet therapy after coronary stenting - AICT-AsiaPCR 2021

PCR

ESC TV at #ESCCongress 2021 - STOPDAPT-2 ACS

European Society of Cardiology

Dual anti-platelet therapy: How Long after PCI, CABG, ACS?

Heart Minute | Dual Antiplatelet Therapy after Ischemic Stroke or TIA

American College of Cardiology

Journal Club - Dual Antiplatelet therapy after PCI in Patients at High Bleeding Risk (MASTER DAPT)

Yale Interventional Cardiology

DAPT in 2023: How low can you go?

The Changing Face of Dual Anti-Platelet Therapy: Implications for the Internist

ClevelandClinicCME

Dual antiplatelet therapy beyond 1 year after coronary stenting

Johnson Francis, MBBS, MD, DM

STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS | Dr Hirotoshi Watanabe

Radcliffe Cardiology

Onyx ONE: aspirin vs. P2Y12 after 1-month dual antiplatelet therapy for high bleeding risk patients

PCR

ACS / Antithrombotics - S. Wassmann

European Society of Cardiology

Acute coronary syndromes (ACS) management in patients with diabetes

Duke Clinical Research Institute

Optimization of Anti-platelet Therapy in ACS

Interventional Academy

Dual Antiplatelet Therapy for ACS (Discussion) | Deepak Bhatt, MD, MPH

Vasculearn Network

Medicine Grand Rounds: Antiplatelet and Anticoagulation Therapy After PCI 1/28/20

Emory Department of Medicine

ESC 23: STOPDAPT-3: Prasugrel Monotherapy Without Aspirin in Acute Coronary Syndrome Patients

Radcliffe Cardiology

Latest Developments in the Management of ACS

Duke Clinical Research Institute